Rate Contracts For Innovative Molecule Anti Cancer Drugs

Work Description - Supply Of Medicinal Items (anti-cancer Drugs Innovative Molecules) On A One-year Rate Contract Basis For Both Campuses Of Cnci.

The Chittaranjan National Cancer Institute (CNCI) - Kolkata, a distinguished Central Government institution, formally invites eligible and qualified bidders to participate in an Open Tender for the **supply of medicinal items, specifically anti-cancer drugs and innovative molecules**. This critical procurement, identified by Tender Reference Number **CNCI/e NIT-117/2026-27**, seeks to establish a **one-year rate contract basis** to cater to the requirements of both CNCI campuses. The tender falls under the 'Goods' category, focusing on 'Drugs and Pharmaceutical Products', and is structured as an Item Rate contract. Prospective bidders should note the following critical dates: The tender was ePublished on **June 09, 2026, at 03:00 PM**. Document download and online bid submission will commence from **June 10, 2026, at 11:00 AM**. The final deadline for both document download and bid submission is **June 30, 2026, at 02:00 PM**. Bids will be technically opened on **July 01, 2026, at 02:30 PM** at the Chittaranjan National Cancer Institute, Kolkata. There is **no Tender Fee** for this procurement. However, an Earnest Money Deposit (EMD) of **INR 2,00,000** is mandatory, payable to the "DIRECTOR, CHITTARANJAN NATIONAL CANCER INSTITUTE" at Kolkata, with provisions for EMD exemption for eligible entities. The bidding process will follow a Two-Cover system, encompassing Technical and Financial bids, and submitted bids will remain valid for 180 days. All interested parties are encouraged to download the comprehensive tender documents for detailed specifications and terms. The Tender Inviting Authority is the Director, Chittaranjan National Cancer Institute, located at Street No.299, Plot No. DJ 01, Premises No. 02 0321, Action Area ID, New Town, Kolkata 700160.